MEF2A and Parkinson disease: Among these factors, CTCF, MEF2A, and STAT3 have been associated with Alzheimer’s, Huntington’s, and Parkinson’s diseases (Gonzalez et al., 2007; De Souza et al., 2016; Wu et al., 2017).